Chemoinformaics analysis of 3,4,5-TRI-O-GALLOYLSHIKIMIC-ACID
Molecular Weight | 630.467 | nRot | 7 |
Heavy Atom Molecular Weight | 608.291 | nRig | 28 |
Exact Molecular Weight | 630.086 | nRing | 4 |
Solubility: LogS | -2.639 | nHRing | 0 |
Solubility: LogP | 1.529 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 67 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 3 |
nHetero | 17 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
No. of Oxygen atom | 17 | No. of Arom Bond | 18 |
nHA | 16 | APOL | 75.0634 |
nHD | 10 | BPOL | 30.7506 |
QED | 0.1 |
Synth | 4.154 |
Natural Product Likeliness | 0.925 |
NR-PPAR-gamma | 0.302 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.005 |
Pgp-sub | 0 |
HIA | 0.992 |
CACO-2 | -6.81 |
MDCK | 0.00000745 |
BBB | 0.014 |
PPB | 0.85617 |
VDSS | 0.412 |
FU | 0.159185 |
CYP1A2-inh | 0.465 |
CYP1A2-sub | 0.008 |
CYP2c19-inh | 0.023 |
CYP2c19-sub | 0.019 |
CYP2c9-inh | 0.489 |
CYP2c9-sub | 0.031 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.076 |
CYP3a4-inh | 0.022 |
CYP3a4-sub | 0.013 |
CL | 11.953 |
T12 | 0.985 |
hERG | 0.018 |
Ames | 0.019 |
ROA | 0.002 |
SkinSen | 0.951 |
Carcinogencity | 0.028 |
EI | 0.92 |
Respiratory | 0.007 |
NR-Aromatase | 0.233 |
Antiviral | Yes |
Prediction | 0.745248 |